Connection
Virginia Borges to Drug Delivery Systems
This is a "connection" page, showing publications Virginia Borges has written about Drug Delivery Systems.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.131 |
|
|
|
-
Hirsch FR, Mok TS, Borges V, Bunn PA. Molecularly targeted therapy: when to stop and when to continue? Lancet Oncol. 2010 Aug; 11(8):709-11.
Score: 0.066
-
Kabos P, Borges VF. Fulvestrant: a unique antiendocrine agent for estrogen-sensitive breast cancer. Expert Opin Pharmacother. 2010 Apr; 11(5):807-16.
Score: 0.065